These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14671400)

  • 21. Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion.
    Živičnjak M; Schnabel D; Staude H; Even G; Marx M; Beetz R; Holder M; Billing H; Fischer DC; Rabl W; Schumacher M; Hiort O; Haffner D;
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2097-105. PubMed ID: 21994957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acromesomelic Dysplasia, Type Maroteaux: Impact of Long-Term (8 Years) High-Dose Growth Hormone Treatment on Growth Velocity and Final Height in 2 Siblings.
    Arya VB; Raj M; Younes M; Chapman S; Irving M; Kapoor RR; Buchanan CR
    Horm Res Paediatr; 2020; 93(5):335-342. PubMed ID: 33238275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anthropometric parameters prognosticating a good final height in patients with Turner syndrome during growth hormone therapy].
    Kucharska AM; Majcher A; Rymkiewicz-Kluczyńska B
    Pediatr Endocrinol Diabetes Metab; 2007; 13(3):165-70. PubMed ID: 17880828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analyses from a centre of short- and long-term growth in Turner's syndrome on standard growth hormone doses confirm growth prediction algorithms and show normal IGF-I levels.
    Ranke MB; Schweizer R; Martin DD; Ehehalt S; Schwarze CP; Serra F; Binder G
    Horm Res Paediatr; 2012; 77(4):214-21. PubMed ID: 22433161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of somatropin (recombinant growth hormone) in children of short stature.
    Mehta A; Hindmarsh PC
    Paediatr Drugs; 2002; 4(1):37-47. PubMed ID: 11817985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved final height with long-term growth hormone treatment in Noonan syndrome.
    Osio D; Dahlgren J; Wikland KA; Westphal O
    Acta Paediatr; 2005 Sep; 94(9):1232-7. PubMed ID: 16203673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data.
    Reinehr T; Lindberg A; Koltowska-Häggström M; Ranke M
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):721-6. PubMed ID: 24750131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of achondroplasia with growth hormone: six years of experience.
    Ramaswami U; Rumsby G; Spoudeas HA; Hindmarsh PC; Brook CG
    Pediatr Res; 1999 Oct; 46(4):435-9. PubMed ID: 10509364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.
    Cappa M; Iughetti L; Loche S; Maghnie M; Vottero A;
    J Endocrinol Invest; 2016 Jun; 39(6):667-77. PubMed ID: 27223400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GH therapy in Noonan syndrome: Review of final height data.
    Dahlgren J
    Horm Res; 2009 Dec; 72 Suppl 2():46-8. PubMed ID: 20029237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone treatment in children with Noonan's syndrome: four year results of a partly controlled trial.
    Noordam C; Van der Burgt I; Sengers RC; Delemarre-van de Waal HA; Otten BJ
    Acta Paediatr; 2001 Aug; 90(8):889-94. PubMed ID: 11529537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets.
    Meyerhoff N; Haffner D; Staude H; Wühl E; Marx M; Beetz R; Querfeld U; Holder M; Billing H; Rabl W; Schröder C; Hiort O; Brämswig JH; Richter-Unruh A; Schnabel D; Živičnjak M;
    Pediatr Nephrol; 2018 Mar; 33(3):447-456. PubMed ID: 29058153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Height Outcome of Recombinant Human Growth Hormone Treatment in Achondroplasia Children: A Meta-Analysis.
    Miccoli M; Bertelloni S; Massart F
    Horm Res Paediatr; 2016; 86(1):27-34. PubMed ID: 27355624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age.
    Arends NJ; Boonstra VH; Hokken-Koelega AC
    Pediatrics; 2004 Sep; 114(3):683-90. PubMed ID: 15342839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study.
    Şıklar Z; Genens M; Poyrazoğlu Ş; Baş F; Darendeliler F; Bundak R; Aycan Z; Savaş Erdeve Ş; Çetinkaya S; Güven A; Abalı S; Atay Z; Turan S; Kara C; Can Yılmaz G; Akyürek N; Abacı A; Çelmeli G; Sarı E; Bolu S; Korkmaz HA; Şimşek E; Çatlı G; Büyükinan M; Çayır A; Evliyaoğlu O; İşgüven P; Özgen T; Hatipoğlu N; Elhan AH; Berberoğlu M
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):305-12. PubMed ID: 27125300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome.
    Ranke MB; Lindberg A; Brosz M; Kaspers S; Loftus J; Wollmann H; Kołtowska-Haggstrom M; Roelants M
    Horm Res Paediatr; 2012; 78(1):8-17. PubMed ID: 22832697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.
    Ranke MB; Lindberg A; Ferrández Longás A; Darendeliler F; Albertsson-Wikland K; Dunger D; Cutfield WS; Tauber M; Wilton P; Wollmann HA; Reiter EO;
    Pediatr Res; 2007 Jan; 61(1):105-10. PubMed ID: 17211150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.